NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

AIDS Vaccine Week


Susan Hasty, Publisher
Table of Contents . . . October 19th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in AIDS Vaccine Week | Other Publications

University of Texas Health Science Center at Houston - New chemically activated antigen could expedite development of HIV vaccine

Cancer Vaccines - PDS Biotechnology Corporation Demonstrates Pre-Clinical Safety of its Versamune(TM)-Based HPV Product

HIV/AIDS - Data on HIV/AIDS reported by researchers at Rockefeller University

HIV/AIDS - New findings from E.S. Gray and co-authors describe advances in HIV/AIDS

HIV/AIDS - Studies from B. Mester and co-researchers yield new data on HIV/AIDS

Immunization - Study data from University of Tokyo update knowledge of immunization

2009 New England Regional Minority Health Conference - Regional Minority Health Conference Showcases Solutions to Eliminating Health Disparities

Cancer Vaccines - Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations



Return to Top of Page

-----------------------
PR Login